Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Yescarta

Yescarta 0.4 – 2 × 108 cells dispersion for infusion · Abschnitt 4.8 · PDF-Seite 11–12

HOS-139698 · Präparat HOS-098384

11 System Organ Class (SOC) Frequency Adverse reactions Nervous system disorders Very common Encephalopathyg Tremorh Headachei Dizzinessj Common Ataxiak Seizures, including status epilepticus Hemiparesis Facial paralysisl Neuropathy peripheralm Myoclonus Uncommon Quadriplegia Spinal cord oedema Myelitis Dyscalculia Cerebral oedema## Eye disorders Common Visual impairmentn Cardiac disorders Very common Tachycardiao Arrhythmiap Common Cardiac arrest Cardiac failureq Vascular disorders Very common Hypotensionr Hypertension Common Thrombosiss Haemorrhaget Respiratory, thoracic and mediastinal disorders Very common Coughu Common Respiratory failurev Hypoxiaw Pleural effusion Pulmonary oedema Dyspnoeax Nasal inflammationy Gastrointestinal disorders Very common Vomiting Diarrhoeaz Constipation Abdominal painaa Nausea Common Dysphagia*** Dry mouthbb Hepatobiliary disorders Very common Transaminases increasedcc Common Hyperbilirubinaemiadd Skin and subcutaneous tissue disorders Very common Rashee Musculoskeletal and connective tissue disorders Very common Motor dysfunctionff Musculoskeletal paingg Uncommon Rhabdomyolysis Renal and urinary disorders Common Renal impairmenthh General disorders and administration site conditions Very common Feverii Oedemajj Fatiguekk Chills

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.